Juvenile granulosa cell tumor in a transgender male with Ollier disease: A case report

• Multiple case reports are published on patients with Ollier’s disease presenting simultaneously with granulosa cell tumors. • More medical conditions are being treated with androgens and estrogens, including gender dysphoria. • Caution should be given to transgender patients on active hormonal the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ing, Brandon I., Huepenbecker, Sarah P., Hameed, Nadia, Lu, Karen H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Survey Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569971/
https://www.ncbi.nlm.nih.gov/pubmed/37840846
http://dx.doi.org/10.1016/j.gore.2023.101287
_version_ 1785119660322062336
author Ing, Brandon I.
Huepenbecker, Sarah P.
Hameed, Nadia
Lu, Karen H.
author_facet Ing, Brandon I.
Huepenbecker, Sarah P.
Hameed, Nadia
Lu, Karen H.
author_sort Ing, Brandon I.
collection PubMed
description • Multiple case reports are published on patients with Ollier’s disease presenting simultaneously with granulosa cell tumors. • More medical conditions are being treated with androgens and estrogens, including gender dysphoria. • Caution should be given to transgender patients on active hormonal therapy. • Providers should consider prescreening for hormonally responsive medical conditions.
format Online
Article
Text
id pubmed-10569971
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105699712023-10-14 Juvenile granulosa cell tumor in a transgender male with Ollier disease: A case report Ing, Brandon I. Huepenbecker, Sarah P. Hameed, Nadia Lu, Karen H. Gynecol Oncol Rep Survey Article • Multiple case reports are published on patients with Ollier’s disease presenting simultaneously with granulosa cell tumors. • More medical conditions are being treated with androgens and estrogens, including gender dysphoria. • Caution should be given to transgender patients on active hormonal therapy. • Providers should consider prescreening for hormonally responsive medical conditions. Elsevier 2023-10-02 /pmc/articles/PMC10569971/ /pubmed/37840846 http://dx.doi.org/10.1016/j.gore.2023.101287 Text en © 2023 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Survey Article
Ing, Brandon I.
Huepenbecker, Sarah P.
Hameed, Nadia
Lu, Karen H.
Juvenile granulosa cell tumor in a transgender male with Ollier disease: A case report
title Juvenile granulosa cell tumor in a transgender male with Ollier disease: A case report
title_full Juvenile granulosa cell tumor in a transgender male with Ollier disease: A case report
title_fullStr Juvenile granulosa cell tumor in a transgender male with Ollier disease: A case report
title_full_unstemmed Juvenile granulosa cell tumor in a transgender male with Ollier disease: A case report
title_short Juvenile granulosa cell tumor in a transgender male with Ollier disease: A case report
title_sort juvenile granulosa cell tumor in a transgender male with ollier disease: a case report
topic Survey Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569971/
https://www.ncbi.nlm.nih.gov/pubmed/37840846
http://dx.doi.org/10.1016/j.gore.2023.101287
work_keys_str_mv AT ingbrandoni juvenilegranulosacelltumorinatransgendermalewithollierdiseaseacasereport
AT huepenbeckersarahp juvenilegranulosacelltumorinatransgendermalewithollierdiseaseacasereport
AT hameednadia juvenilegranulosacelltumorinatransgendermalewithollierdiseaseacasereport
AT lukarenh juvenilegranulosacelltumorinatransgendermalewithollierdiseaseacasereport

Ejemplares similares